Mary F Brunette
Affiliation: Dartmouth Medical School
- Psychosocial interventions for the long-term management of patients with severe mental illness and co-occurring substance use disorderMary F Brunette
Department of Psychiatry, Dartmouth Medical School, Hanover, NH 03301, USA
J Clin Psychiatry 67:10-7. 2006..The stages of change, the stages of treatment, and the psychosocial strategies used at each stage of treatment are outlined...
- Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disordersMary F Brunette
Department of Psychiatry, Dartmouth Medical School, New Hampshire Dartmouth Psychiatric Research Center, Concord, NH 03301, USA
Schizophr Bull 32:637-43. 2006..This research, however, could be biased by selection factors. Studying patients who are currently in substance abuse remission could control for level of motivation to stop using substances and other methodological confounds...
- Benzodiazepine prescription practices and substance abuse in persons with severe mental illnessRobin E Clark
Department of Community and Family Medicine, New Hampshire Dartmouth Psychiatric Research Center at Dartmouth Medical School, Hanover, NH, USA
J Clin Psychiatry 65:151-5. 2004..The objectives of this study were to determine the prevalence of benzodiazepine use among persons with psychiatric disorders and to evaluate compliance with published prescribing guidelines...
- Carbon monoxide feedback in a motivational decision support system for nicotine dependence among smokers with severe mental illnessesMary F Brunette
Geisel School of Medicine at Dartmouth and Dartmouth Psychiatric Research Center, Concord, NH 03301, USA
J Subst Abuse Treat 45:319-24. 2013..This study suggests that a computerized motivational decision support system can lead users to initiate cessation treatment, and that carbon monoxide feedback is not a necessary component. ..
- Substance abuse and schizophrenia: pharmacotherapeutic interventionAlan I Green
Department of Psychiatry, Dartmouth Medical School, Lebanon, NH 03756, USA
J Subst Abuse Treat 34:61-71. 2008..Further studies are required to establish a solid evidence base of best practices for the use of medications in these patients...
- Implementation of integrated dual disorders treatment: a qualitative analysis of facilitators and barriersMary F Brunette
Department of Psychiatry, Dartmouth Medical School, and Dartmouth Psychiatric Research Center, State Office Park South, 105 Pleasant St, Concord, NH 03301, USA
Psychiatr Serv 59:989-95. 2008..This report describes the extent to which this intervention was implemented by 11 community mental health centers participating in a large study of practice implementation. Facilitators and barriers to implementation are described...
- Schizophrenia and co-occurring substance use disorderAlan I Green
Department of Psychiatry, Dartmouth Medical School, Hanover, NH, USA
Am J Psychiatry 164:402-8. 2007
- A review of treatments for people with severe mental illnesses and co-occurring substance use disordersRobert E Drake
New Hampshire Dartmouth Psychiatric Research Center, Dartmouth Medical School, Lebanon, New Hampshire, USA
Psychiatr Rehabil J 27:360-74. 2004..Current research aims to refine and test individual components and combinations of integrated treatments...
- Do smoking cessation websites meet the needs of smokers with severe mental illnesses?Mary F Brunette
Dartmouth Medical School, Psychiatric Research Center, 105 Pleasant St, Concord, NH 03303, USA
Health Educ Res 27:183-90. 2012..Although the Internet is a promising strategy to provide education about treatments, website developers must attend to the needs and capacities of multiple user groups...
- An electronic decision support system to motivate people with severe mental illnesses to quit smokingMary F Brunette
Department of Psychiatry, Dartmouth Psychiatric Research Center, Concord, NH 03301, USA
Psychiatr Serv 62:360-6. 2011..The authors developed a Web-based computer decision support system that is tailored for use by people with cognitive deficits and is designed to stimulate motivation to quit smoking by using evidence-based treatment...
- Integrated family treatment for parents with severe psychiatric disabilitiesMary F Brunette
Dartmouth Medical School, New Hampshire, USA
Psychiatr Rehabil J 28:177-80. 2004..Six of the seven parents (85.7%) remaining in treatment improved on one or more measure of parent skills. Integrated Family Treatment is a promising practice that warrants further study...
- Hepatitis C treatment for people with severe mental illnessLisa A Mistler
Dartmouth Medical School, Hanover NH, USA
Psychosomatics 47:93-107. 2006..This article reviews the available data on neuropsychiatric side effects of interferon (IFN) treatment, discusses the limitations of the current research, and makes recommendations regarding HCV treatment in persons with SMI...
- Case report of 3 patients with severe mental illness and chronic hepatitis C virus infection treated with interferon-alphaLisa A Mistler
Dartmouth College Medical School and New Hampshire Hospital, USA
Int J Psychiatry Med 36:449-55. 2006..These case reports add support to the growing body of evidence that persons with severe mental illness and substance use disorders can be successfully treated for hepatitis C with careful monitoring and psychiatric oversight...
- Community mental health care for women with severe mental illness who are parentsMary F Brunette
New Hampshire Dartmouth Psychiatric Research Center, Concord 03301, USA
Community Ment Health J 38:153-65. 2002..This paper describes services to help clients who are parents, which includes integration of adult's and children's services, long-term, home-based parent training, and linkage with community supports...
- Enhancing validity in co-occurring disorders treatment researchGregory J McHugo
Dartmouth Psychiatric Research Center, 2 Whipple Place, Suite 202, Lebanon, NH 03766, USA
Schizophr Bull 32:655-65. 2006..The central recommendation is to move rapidly from efficacy studies to more credible and valid effectiveness studies, in order to facilitate the adoption of evidence-based interventions in routine practice settings...
- A review of research on residential programs for people with severe mental illness and co-occurring substance use disordersMary F Brunette
New Hampshire Dartmouth Psychiatric Research Center and Dartmouth Medical School NH, USA
Drug Alcohol Rev 23:471-81. 2004....
- Responding to blood-borne infections among persons with severe mental illnessMary F Brunette
New Hampshire Dartmouth Psychiatric Research Center and Dartmouth Medical School, 105 Pleasant Street, Concord, New Hampshire 03301, USA
Psychiatr Serv 54:860-5. 2003..In addition, expansion of integrated dual disorders treatments and improving linkage with specialty medical care providers are recommended...
- Pharmacotherapy of Co-Occurring Schizophrenia and Substance Use DisordersSarah C Akerman
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA
Curr Addict Rep 1:251-260. 2014..Further research is needed to evaluate optimal pharmacotherapeutic strategies for this population...
- A pre-post pilot study of a brief, web-based intervention to engage disadvantaged smokers into cessation treatmentMary F Brunette
Geisel School of Medicine at Dartmouth, Department of Psychiatry, Psychiatric Research Center, 105 Pleasant St, Concord, NH, 03301, USA
Addict Sci Clin Pract 10:3. 2015..We developed a novel, web-based, motivational, decision-support system that was designed to engage disadvantaged smokers into tobacco cessation treatment. We piloted the system among smokers in a primary care safety net clinic...
- Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use disordersStanley D Rosenberg
Dartmouth Medical School, Dartmouth College, Lebanon, NH 03756, USA
AIDS 19:S26-33. 2005..However, little is known about HIV/HCV co-infection in this population. This paper examines the prevalence and correlates of HIV, hepatitis C, and HIV/HCV co-infection in a large, multisite sample of SMI clients...
- Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?Robert M Roth
Department of Psychiatry, Dartmouth Medical School DHMC, Lebanon, NH 03756, USA
Curr Psychiatry Rep 7:283-91. 2005..We propose that effective treatments may in part work through the modulation of brain reward circuitry dysfunction...
- Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THCAdina S Fischer
Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, NH, USA
Schizophr Res 158:176-82. 2014..The findings from this pilot study support the use of rs-fc as a means of measuring the integrity of the BRC and the effects of pharmacologic agents acting on this circuit in patients with schizophrenia and CUD...
- Public-academic partnerships: a program to improve the quality of antipsychotic prescribing in a community mental health systemMary F Brunette
Department of Health and Human Services, NHDHHS, Dartmouth Psychiatric Research Center, State Office Park South, 105 Pleasant St, Concord, NH 03301, USA
Psychiatr Serv 62:1004-6. 2011..The program encourages providers at community mental health centers to adopt prescribing practices that limit the cardiometabolic side effects of antipsychotic medicines...
- Management of persons with co-occurring severe mental illness and substance use disorder: program implicationsRobert E Drake
Psychiatric Research Center, Dartmouth Medical School, 2 Whipple Place, Suite 202, Lebanon, NH 03766, USA
World Psychiatry 6:131-6. 2007..The authors overview the current research and offer guidelines related to mission and philosophy, leadership, comprehensive reorganization, training, specific programs, and quality improvement...
- An open-label pilot study of quetiapine plus mirtazapine for heavy drinkers with alcohol use disorderMary F Brunette
Dartmouth Geisel School of Medicine, Department of Psychiatry, Hanover, NH, USA
Alcohol 53:45-50. 2016..These findings are consistent with our previous work in animal models of alcohol use disorders and suggest that further study of medications or combinations of medications with this pharmacologic profile is warranted. ..
- Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disordersMary F Brunette
Department of Psychiatry, Dartmouth Medical School, Concord, New Hampshire 03301, USA
Psychiatr Serv 54:1395-401. 2003..The authors examined benzodiazepine use and associated psychiatric, substance abuse, and institutional outcomes in a six-year longitudinal study of patients with co-occurring disorders...
- Development of a scale to assess practitioner knowledge in providing integrated dual disorders treatmentMichelle P Salyers
ACT Center of Indiana, Roudebush VA Medical Center, 1481 West 10th Street 11H, Indianapolis, IN 46202, USA
Adm Policy Ment Health 34:570-81. 2007..Higher scores on the scale were correlated with greater education, but not greater experience or lower burnout. This test is a promising tool for assessing provider knowledge of a specific evidence-based practice...